Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,564,173
-$1,480,467 QoQ
Shares Held
274,831
-32.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#98
of 640 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Horizon Investments, LLC holds $36,074,962 across 11 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
23,364 | $12,659,316 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
71,090 | $11,981,508 | |
| 3 | HLN |
Haleon plc
This page
|
274,831 | $2,564,173 | |
| 4 | VTRS |
Viatris Inc
|
125,321 | $1,990,097 | |
| 5 | ZTS |
Zoetis Inc.
|
24,833 | $1,784,499 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,561 | $1,543,606 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
25,390 | $1,041,751 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
9,779 | $809,505 |
All Filings in HLN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,564,173 | 274,831 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,044,640 | 404,060 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,145,089 | 212,175 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,873,106 | 208,819 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||